Concepedia

Tamara Iglesias

TI

Statistics

Publications

8

Citations

471

H-Index

8

Active since

2009

Affiliations

Universidad de Navarra(Current)

Navarre Institute of Health Research

Universidad de la República de Uruguay

Tamara Iglesias is an author at Universidad de Navarra specializing in oncology, checkpoint inhibitor therapy, and oral drug delivery systems.

Publications per year

2009–2021

8

Publications

8

Feasibility of biohydrogen production from cheese whey using a UASB reactor: Links between microbial community and reactor performance

Elena Castelló, Carmen García y Santos, Tamara Iglesias et al. · International Journal of Hydrogen Energy · 2009 · 204 citations

Life Sciences, Biotechnology, Microbiology +17

Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model

Diana Llópiz, Marta Ruiz, Lorea Villanueva et al. · Cancer Immunology Immunotherapy · 2018 · 138 citations · Full text

Medicine, Oncology, Pharmacology +15

Evaluation of the cytotoxicity, genotoxicity and mucus permeation capacity of several surface modified poly(anhydride) nanoparticles designed for oral drug delivery

Tamara Iglesias, Adela López de Ceráin, Nekane Martín‐Arbella et al. · International Journal of Pharmaceutics · 2016 · 39 citations

Pharmacy, Pharmaceutics, Pharmacology +16

Seroprevalence of leptospirosis in human groups at risk due to environmental, labor or social conditions

Paulina Meny, Clara Menéndez, Natalia Ashfield et al. · Revista Argentina de Microbiología · 2019 · 26 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

In vitro evaluation of the genotoxicity of poly(anhydride) nanoparticles designed for oral drug delivery

Tamara Iglesias, Mária Dušinská, Naouale El Yamani et al. · International Journal of Pharmaceutics · 2017 · 23 citations · Full text

Pharmacy, Pharmaceutics, Toxicology +14

1–5 of 8